Buffington Mohr Mc Neal Abbott Laboratories Transaction History

Buffington Mohr Mc Neal

$605 Million
Q3 2024

A detailed history of Buffington Mohr Mc Neal transactions in Abbott Laboratories stock. As of the latest transaction made, Buffington Mohr Mc Neal holds 73,428 shares of ABT stock, worth $8.46 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares

73,428

Previous 79,516 7.66%

Holding current value

$8.46 Million

Previous $8.26 Million 1.32%

% of portfolio

1.38%

Previous 1.45%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$100.07 - $118.13 $609,226 - $719,175	-6,088 Reduced 7.66%	73,428 $8.37 Million
Q2 2024 Jul 11, 2024	SELL	$100.73 - $112.44 $1.38 Million - $1.54 Million	-13,718 Reduced 14.71%	79,516 $8.26 Million
Q1 2024 Apr 18, 2024	BUY	$109.52 - $120.96 $185,636 - $205,027	1,695 Added 1.85%	93,234 $10.6 Million
Q4 2023 Jan 30, 2024	SELL	$90.19 - $110.4 $148,903 - $182,270	-1,651 Reduced 1.77%	91,539 $10.1 Million
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $4,394 - $5,272	-46 Reduced 0.05%	93,190 $9.03 Million
Q2 2023 Jul 25, 2023	SELL	$100.78 - $112.29 $71,654 - $79,838	-711 Reduced 0.76%	93,236 $10.2 Million
Q1 2023 Apr 26, 2023	BUY	$96.86 - $114.01 $151,004 - $177,741	1,559 Added 1.69%	93,947 $9.51 Million
Q4 2022 Jan 19, 2023	BUY	$95.06 - $111.52 $4,182 - $4,906	44 Added 0.05%	92,388 $0
Q3 2022 Oct 11, 2022	BUY	$96.76 - $112.03 $20,416 - $23,638	211 Added 0.23%	92,344 $8.94 Million
Q2 2022 Jul 19, 2022	BUY	$102.07 - $123.37 $88,902 - $107,455	871 Added 0.95%	92,133 $10 Million
Q1 2022 May 02, 2022	BUY	$114.02 - $139.04 $2,850 - $3,476	25 Added 0.03%	91,262 $10.8 Million
Q4 2021 Jan 27, 2022	BUY	$115.53 - $141.46 $57,071 - $69,881	494 Added 0.54%	91,237 $12.8 Million
Q3 2021 Oct 13, 2021	BUY	$116.66 - $129.06 $13,182 - $14,583	113 Added 0.12%	90,743 $10.7 Million
Q2 2021 Jul 28, 2021	SELL	$105.79 - $124.53 $54,481 - $64,132	-515 Reduced 0.57%	90,630 $10.5 Million
Q1 2021 Apr 14, 2021	BUY	$108.84 - $128.23 $217,462 - $256,203	1,998 Added 2.24%	91,145 $10.9 Million
Q4 2020 Jan 20, 2021	BUY	$105.0 - $114.42 $157,185 - $171,286	1,497 Added 1.71%	89,147 $9.76 Million
Q3 2020 Oct 26, 2020	SELL	$91.64 - $111.29 $31,615 - $38,395	-345 Reduced 0.39%	87,650 $9.54 Million
Q2 2020 Jul 27, 2020	BUY	$76.57 - $98.0 $85,605 - $109,564	1,118 Added 1.29%	87,995 $8.05 Million
Q1 2020 Apr 08, 2020	BUY	$62.82 - $91.86 $86,314 - $126,215	1,374 Added 1.61%	86,877 $6.86 Million
Q4 2019 Jan 30, 2020	BUY	$78.51 - $87.4 $45,928 - $51,129	585 Added 0.69%	85,503 $7.43 Million
Q3 2019 Oct 10, 2019	BUY	$81.84 - $88.74 $66,290 - $71,879	810 Added 0.96%	84,918 $7.11 Million
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $31,338 - $36,550	-430 Reduced 0.51%	84,108 $7.07 Million
Q1 2019 Apr 29, 2019	BUY	$66.22 - $80.06 $20,726 - $25,058	313 Added 0.37%	84,538 $6.76 Million
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $284,333 - $322,108	4,337 Added 5.43%	84,225 $6.09 Million
Q3 2018 Oct 25, 2018	BUY	$60.81 - $73.36 $104,775 - $126,399	1,723 Added 2.2%	79,888 $5.86 Million
Q2 2018 Jul 30, 2018	BUY	$57.57 - $63.54 $84,915 - $93,721	1,475 Added 1.92%	78,165 $4.77 Million
Q1 2018 Apr 26, 2018	BUY	$56.27 - $63.62 $237,740 - $268,794	4,225 Added 5.83%	76,690 $4.6 Million
Q4 2017 Jan 25, 2018	BUY	$53.68 - $57.47 $22,008 - $23,562	410 Added 0.57%	72,465 $4.14 Million
Q3 2017 Oct 30, 2017	BUY	$48.06 - $53.64 $3.46 Million - $3.87 Million	72,055	72,055 $3.99 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buffington Mohr Mc Neal, based on Form 13F filings with the SEC.

News

Stay updated on Buffington Mohr Mc Neal with notifications on news.

Account

Buffington Mohr Mc Neal Abbott Laboratories Transaction History